The therapeutic potential of the current findings was revealed by our identification of the AHR ligand A18 to prevent NEC when fed to mice during pregnancy, and by showing its ability to reduce TLR4 signaling in human bowel ex vivo. Here, TLR4 is linked to necrotizing enterocolitis.